Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Bioceres Crop Solutions Corp. (BIOX)

0.2145 -0.0229 (-9.65%)
At close: 4:00:00 PM EST
0.2200 +0.0055 (+2.56%)
After hours: 6:31:17 PM EST
Chart Range Bar
Loading chart for BIOX
  • Previous Close 0.2374
  • Open 0.2374
  • Bid 0.2104 x 800
  • Ask 0.4586 x 200
  • Day's Range 0.2122 - 0.2398
  • 52 Week Range 0.1900 - 2.0300
  • Volume 62,971
  • Avg. Volume 324,014
  • Market Cap (intraday) 13.689M
  • Beta (5Y Monthly) 0.57
  • PE Ratio (TTM) --
  • EPS (TTM) -1.2000
  • Earnings Date (est.) Nov 12, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions in Argentina, Brazil, the rest of Latin America, and internationally. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The company offers biological crop nutrition products comprising seed inoculants under the Rizoliq and UHC brands, biofertilizers, and biostimulants; biocontrol products, including bionematicides, biofungicides, and bioinsecticides; crop nutrition and crop protection products, such as micro-beaded fertilizers and adjuvants; and seed germplasms, GMO and non-GMO traits, and ready-to-use seed treatment pack solutions for healthier and higher yielding crops. It also provides fungicide products under the Rizoderma brand; Rizofos for foliar applications; therapies, herbicides, and baits; and bio-inductors, crop health products, and biological and micro granulated fertilizers. In addition, the company licenses its HB4 seed trait for drought tolerance in wheat and soybean seeds. It sells its products to blue-chip companies and industry leaders, large distributors, co-ops, dealers, large farmers, and individual growers through distributors and dealers. The company was founded in 2001 and is headquartered in Rosario, Argentina.

investors.biocerescrops.com

562

Full Time Employees

June 30

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 11/10/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BIOX
83.63%
S&P 500 (^GSPC)
9.87%

1-Year Return

BIOX
87.67%
S&P 500 (^GSPC)
10.08%

3-Year Return

BIOX
97.92%
S&P 500 (^GSPC)
70.34%

5-Year Return

BIOX
98.36%
S&P 500 (^GSPC)
61.85%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 39.4M
Earnings -9M
Profit Margin -22.84%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

-150M
-100M
-50M
0
50M
-200.0%
-150.0%
-100.0%
-50.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -108.54%

  • Return on Assets (ttm)

    -0.83%

  • Return on Equity (ttm)

    -50.07%

  • Revenue (ttm)

    237.84M

  • Net Income Avi to Common (ttm)

    -76.65M

  • Diluted EPS (ttm)

    -1.2000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    12.2M

  • Total Debt/Equity (mrq)

    369.42%

  • Levered Free Cash Flow (ttm)

    45.61M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: